Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Thompson Travis AlvinCHIEF ACCOUNTING OFFICER | Grant or award | A | — 75.0K sh | Jan 6, 2026 |
| 9 | Krawczyk Joseph R IISR. VP, WW CLIENT ENGAGEMENT | Grant or award | A | — 122 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 9 | Carlson Anthony JDirector, President and CEO | Option exercise | M | — 5,022 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 9 | Sparks Paul EugeneDirector | Grant or award | A | — 982.6K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 9 | Arntzen Christopher JSVP, GC & Secretary | Grant or award | A | — 7,488 sh | Jan 6, 2026 traded Jan 3, 2026 |
| 9 | Gravier PierreCHIEF FINANCIAL OFFICER | Grant or award | A | — 50.0K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 9 | Sanders Reginald J.Director | Grant or award | A | — 40.0K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 9 | Rayphole Robert P.VP CAO & Controller | Option exercise | M | — 720 sh | Jan 6, 2026 traded Jan 4, 2026 |
| 9 | Duty StuartDirector | Grant or award | A | — 40.0K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 9 | Roberts Malcolm JamesEVP & Chief Commercial Officer | Tax withholding | F | $12K 381 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 9 | Bowman Erica SVICE PRESIDENT | Disposition to issuer | D | $4.19 0 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 8 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $33K 161 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 8 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $36K 177 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 8 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $10K 52 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 8 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $18K 86 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 7 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $381K 1,659 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 7 | Lin MarkEVP and CFO | Option exercise · 10b5-1 plan | M | — 3,164 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 7 | Singh VikasEVP & Chief Financial Officer | Option exercise · 10b5-1 plan | M | — 3,980 sh | Jan 6, 2026 traded Jan 3, 2026 |
| 7 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $295K 1,292 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 6 | Lin MarkEVP and CFO | Tax withholding · 10b5-1 plan | F | $88K 1,198 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 6 | Sieffert Kristen NPresident | Open-market sale · 10b5-1 plan | SELL | $18K 750 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 5 | Krupka Devin MController, PAO | Option exercise | M | — 352 sh | Jan 6, 2026 traded Jan 3, 2026 |
| 5 | Fitzpatrick JenniferChief Legal Officer | Grant or award | A | — 103.1K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 5 | Ribeiro RamiroChief Medical Officer | Option exercise | M | — 19.7K sh | Jan 6, 2026 traded Jan 3, 2026 |
| 5 | Olsson ShawnChief Commercial Officer | Grant or award | A | — 14.0K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 5 | Olsson ShawnChief Commercial Officer | Grant or award | A | — 84.2K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 5 | Krupka Devin MController, PAO | Option exercise | M | — 352 sh | Jan 6, 2026 traded Jan 3, 2026 |
| 5 | Cowan ChadChief Scientific Officer | Tax withholding | F | $1,603 1,611 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 5 | Ribeiro RamiroChief Medical Officer | Grant or award | A | — 85.7K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 5 | O'Connor John TerryGeneral Counsel | Grant or award | A | — 15.0K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 5 | Krupka Devin MController, PAO | Tax withholding | F | $1,692 119 sh | Jan 6, 2026 traded Jan 3, 2026 |
| 5 | Ribeiro RamiroChief Medical Officer | Grant or award | A | — 171.4K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 3 | Lin MarkEVP and CFO | Option exercise · 10b5-1 plan | M | — 3,164 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 3 | Spice Adam C.Chief Financial Officer | Option exercise · 10b5-1 plan | M | — 731.3K sh | Jan 6, 2026 traded Jan 5, 2026 |
| 3 | Kelleher Eric RobertSee Remarks | Derivative conversion · 10b5-1 plan | C | — 2,409 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 3 | Bachrodt AmySVP, Finance | Option exercise · 10b5-1 plan | M | $50K 4,796 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 0 | Bernstein HaroldPresident, R&D & CMO | Option exercise · 10b5-1 plan | M | — 4,432 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 0 | Bernstein HaroldPresident, R&D & CMO | Option exercise · 10b5-1 plan | M | $46K 4,432 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 0 | Kozarich John WDirector | Open-market sale · 10b5-1 plan | SELL | $19K 102 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 0 | Graham-Cumming JohnDirector | Option exercise · 10b5-1 plan | M | — 2,520 sh | Jan 6, 2026 traded Jan 5, 2026 |